Carlsmed, Inc.
CARL
$9.99
-$0.87-8.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 85.94% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 85.94% | -- | -- | -- | |
| Cost of Revenue | 75.23% | -- | -- | -- | |
| Gross Profit | 89.74% | -- | -- | -- | |
| SG&A Expenses | 72.75% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 58.10% | -- | -- | -- | |
| Operating Income | -26.75% | -- | -- | -- | |
| Income Before Tax | -22.17% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -22.17% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -22.17% | -- | -- | -- | |
| EBIT | -26.75% | -- | -- | -- | |
| EBITDA | -26.34% | -- | -- | -- | |
| EPS Basic | 39.93% | -- | -- | -- | |
| Normalized Basic EPS | 40.75% | -- | -- | -- | |
| EPS Diluted | 39.93% | -- | -- | -- | |
| Normalized Diluted EPS | 40.75% | -- | -- | -- | |
| Average Basic Shares Outstanding | 247.78% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 247.78% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |